Rhythm Pharmaceuticals (NASDAQ:RYTM) 公布季度每股亏损$(0.72)，符合分析师一致预期。相比去年同期每股亏损$(0.70)，减少了2.86%。公司报告季度销售额为4183万美元，超出分析师一致预期的3848万美元，增长8.69%。相比去年同期销售额2423万美元，增加了72.61%。

以上内容来自Benzinga Earnings专栏，原文如下：

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.72) per share which met the analyst consensus estimate. This is a 2.86 percent decrease over losses of $(0.70) per share from the same period last year. The company reported quarterly sales of $41.83 million which beat the analyst consensus estimate of $38.48 million by 8.69 percent. This is a 72.61 percent increase over sales of $24.23 million the same period last year.